Pivotal study of PT20 in dialysis dependent patients with hyperphosphataemia

Trial Profile

Pivotal study of PT20 in dialysis dependent patients with hyperphosphataemia

Planning
Phase of Trial: Phase II

Latest Information Update: 04 Mar 2015

At a glance

  • Drugs PT 20 (Primary)
  • Indications Hyperphosphataemia
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 04 Mar 2015 As per a Phosphate Therapeutics media release, doses and regimen from other pivotal trial will be used in this trial. The data from these two trials will form the basis of NDAs for approval of PT20 in dialysis dependent patients with hyperphosphataemia
    • 03 Mar 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top